Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Contraceptives Market?

The size of the contraceptives market has experienced robust growth in the recent past. The market, which was valued at $27.92 billion in 2024, is projected to increase to $29.74 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.5%. Factors such as the introduction of birth control pills, heightened awareness and education pertaining to contraception, legislative and societal shifts favouring reproductive rights, worldwide population control measures, and a rise in the usage of generic and affordable drugs and devices have contributed to the growth experienced during the historic period.

In the next few years, the contraceptives market is anticipated to experience robust growth. It is projected to expand to “$40 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. This impending growth during the forecast period can be linked to the increasing interest in male contraceptives, improved access to contraception in developing nations, the integration of digital health technology in contraception, a surge in demand for long-acting reversible contraceptives (LARCS), and growing ease of access to over-the-counter drugs via online platforms. Key trends in the forecast period encompass technological innovations in contraceptive techniques, a shift towards non-hormonal and natural contraceptive methods, broader over-the-counter access to certain contraceptives, focus on user-friendly and discreet contraceptive options, and the inclusion of telemedicine in contraceptive advice and prescriptions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

What Core Drivers Are Expected To Influence The Contraceptives Market?

The growing prevalence of sexually transmitted diseases (STDs) is fuelling the need for contraceptives. STDs are disorders that are transmitted from one individual to another through sexual interaction. They are most commonly spread during anal, vaginal, and oral intercourse, but they can also be transmitted through other close physical contact methods. Contraceptives are used primarily to prevent the transmission of STDs such as herpes and HPV, which are typically transmitted through skin-to-skin contact. For instance, as per the Minnesota Department of Health, a state health agency in the US, the number of primary and secondary syphilis cases rose to 676 in 2022, a 19% increase from 564 in 2021. Similarly, in 2022, 20 cases of newborns with congenital syphilis were reported, reflecting a 42% increase from the previous year, when 14 cases were recorded. Thus, the increase in sexually transmitted diseases or infections is anticipated to heighten the demand for contraceptives in the near future.

What Are The Main Segment Classifications In The Contraceptives Market?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

How Are Industry Trends Steering The Expansion Of The Contraceptives Market?

Leading firms in the contraceptives market are striving to create innovative methods such as the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives. The goal is to improve user convenience, boost efficacy, and offer long-term birth control choices, diminishing the necessity for regular dosing, enhancing availability, and lessening side effects. These advancements contribute to the creation of more dependable and discreet birth control methods for those wanting improved reproductive health management. For example, in October 2023, the Health and Family Welfare Ministry, a government organization based in India, introduced two new techniques, the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive, with the aim to augment family planning services. These approaches form part of the National Family Planning Programme, designed with the aim of improving the health outcomes of mothers and infants. The goal of these birth control methods is to decrease mother and infant morbidity and mortality rates by expanding the choices for family planning. This initiative falls under a wider strategy to improve reproductive health services in Karnataka, ensuring women can access safe and effective contraceptive techniques.

Which Companies Are Contributing Significantly To The Contraceptives Market Growth?

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Which Region Holds The Greatest Opportunity For Contraceptives Market Expansion?

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model